Cresco Labs Inc. (CRLBF): Cost of Revenue
$331.28M
Year ended 2025-12-31
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $331.28M | -7.9% | 2026-03-06, From 2025-01-01 |
| 2024-12-31 | $359.89M | -11.9% | 2026-03-06, From 2024-01-01 |
| 2023-12-31 | $408.52M | n/a | 2025-03-14, From 2023-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Cresco Labs Inc. (CRLBF) | 2025-12-31 | $331.28M | -7.9% |
| Ascend Wellness Holdings, Inc. (AAWH) | 2025-12-31 | $330.90M | -12.3% |
| Tilray Brands, Inc. (TLRY) | 2026-05-31 | $655.01M | +12.8% |
| USANA Health Sciences Inc (USNA) | 2026-01-03 | $200.85M | +24.6% |
| Trulieve Cannabis Corp. (TRLV) | 2025-12-31 | $470.01M | -0.2% |
| Curaleaf Holdings, Inc. (CURLF) | 2025-12-31 | $637.11M | -8.1% |
| Jushi Holdings Inc. (JUSH) | 2025-12-31 | $148.93M | +7.0% |
| Glass House Brands Inc. (GLAS) | 2025-12-31 | $105.02M | +1.5% |
| Marimed Inc. (MRMD) | 2025-12-31 | $101.94M | +7.2% |
Compare CRLBF, AAWH, TLRY, USNA side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗